Real-World Comparative Effectiveness Study of TYVASO (Inhaled Treprostinil) in the Treatment of PH-ILD

12/04/2024
19/08/2025
EU PAS number:
EUPAS1000000109
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Ferrer_PH-ILD_TYVASO_Protocol_V1.0_Signed_19JAN2024.pdf

English (1.05 MB - PDF) View document
Updated protocol

Ferrer_PH-ILD_TYVASO_ECA_protocol_v2.0_09072024_signed.pdf

First published: 22/07/2024
English (2.06 MB - PDF) View document
Study results
Study results

Real-World Comparative Effectiveness Study of TYVASO-Inhaled Treprostinil- in the Treatment of PH-ILD study Abstract.pdf

English (974.4 KB - PDF) View document
Study report
Other information